Wednesday, October 14, 2026
23.7 C
Bengaluru

Pharma and the Covid19 Crisis – An Interaction with Sunil Attavar, CMD, Group Pharma

This is the first part of MedicinMan interview series with pharma business leaders to make sense of the Covid19 crisis and its impact on healthcare industry. Subscribe to MedicinMan to get regular updates of interactions with pharma business leaders.

MedicinMan: Give our readers, a sense of what is happening in the pharma industry since the corona virus outbreak. What are the main areas of impact? How are Indian Pharma leaders responding to these challenges and what are the timelines that they are looking at in terms of the current situation?

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

With over two decades of experience across finance, strategy,...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of...

The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?

The next owner of an Indian hospital may not...

Indian Pharma’s Three Deficits—and Three Potential Dividends

Indian pharma has already done the hard thing once. It...

Topics

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of...

Indian Pharma Is Two Industries Wearing One Label

Indian pharma is often discussed as one sector. In...

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
spot_img

Related Articles

spot_imgspot_img